Ignite Creation Date:
2024-05-06 @ 6:11 PM
Last Modification Date:
2024-10-26 @ 2:43 PM
Study NCT ID:
NCT05576077
Status:
RECRUITING
Last Update Posted:
2024-07-11
First Post:
2022-10-07
Brief Title:
A Study of TBio-4101 TIL and Pembrolizumab in Patients With Advanced Solid Tumors
Sponsor:
Turnstone Biologics Corp
Organization:
Turnstone Biologics Corp
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-01-17
Start Date Type:
ACTUAL
Primary Completion Date:
2024-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-06-30
Completion Date Type:
ESTIMATED
First Submit Date:
2022-10-07
First Submit QC Date:
October 7 2022
Study First Post Date:
2022-10-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-03
Last Update Post Date:
2024-07-11
Last Update Post Date Type:
ACTUAL